期刊
CANCER BIOLOGY & THERAPY
卷 2, 期 3, 页码 242-247出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.2.3.369
关键词
glioblastoma; molecular analysis; phosphatidylinositol 3-kinase (PI3K); PTEN; signal transduction; microarray; gene expressionprofiling
类别
资金
- NCI NIH HHS [U01 CA88127] Funding Source: Medline
- NINDS NIH HHS [NS43147] Funding Source: Medline
Technological advances in the ability to analyze patterns of gene expression and signal transduction pathway activation are improving our understanding of cancer. Previously unrecognized molecular subsets and pathway profiles that convey predictive and prognostic information about individual cancer patients are being identified. Patients with glioblastoma, the most common malignant primary brain tumor of adults, stand to benefit considerably from these advances. Recent data suggest that morphologically indistinguishable glioblastomas have distinct classes of causal oncogene activation, and that these subclasses may be targetable by oncogene/signaling pathway specific therapies. Oncogene/signaling pathway inhibitors show great promise for the treatment of patients with some types of cancer, but their clinical application for glioblastoma has been severely limited by an inability to determine which inhibitor is most likely to benefit a specific patient. Identifying biologically relevant molecular subsets of glioblastoma and detecting pathway profiles that can be used to guide patient therapy are likely to result in significant improvement in the survival of glioblastoma patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据